Rifaximin Alters Intestinal Microbiota and Prevents Progression of Ankylosing Spondylitis in Mice

Recently, accumulating evidence has suggested that gut microbiota may be involved in the occurrence and development of ankylosing spondylitis (AS). It has been suggested that rifaximin have the ability to modulate the gut bacterial communities, prevent inflammatory response, and modulate gut barrier...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Cell Infect Microbiol
Autori principali: Yang, Lianjun, Liu, Bin, Zheng, Junchi, Huang, Jincheng, Zhao, Qinghao, Liu, Jinshi, Su, Zhihai, Wang, Min, Cui, Zhifei, Wang, Tingxuan, Zhang, Weicong, Li, Qingchu, Lu, Hai
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2019
Soggetti:
Cellular and Infection Microbiology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6409347/
https://ncbi.nlm.nih.gov/pubmed/30886835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcimb.2019.00044
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi